2026 Saudi Arabia Riyadh CPHI Middle East International Pharmaceutical Ingredients Exhibition

The 2026 CPHI Middle East International Pharmaceutical Ingredients Exhibition in Riyadh, Saudi Arabia, is a leading event for the pharmaceutical industry in the Middle East and North Africa (MENA) region, dedicated to connecting key players in the global pharmaceutical supply chain. The CPHI brand enjoys a prestigious reputation worldwide, with over 30 years of history, serving as a premier platform for professionals in pharmaceutical ingredients, contract manufacturing, packaging, machinery and equipment, biopharmaceuticals, and finished dosage forms to exchange and collaborate. CPHI Middle East, as its regional flagship exhibition, is held annually, rotating across the Middle East, aiming to serve the region's rapidly growing pharmaceutical market. Saudi Arabia, as the largest economy and an important healthcare market in the Middle East, makes its capital Riyadh an ideal location for this exhibition, providing an excellent opportunity for exhibitors and visitors to gain an in-depth understanding of the local market and expand their business networks. The exhibition is grand in scale, expected to attract hundreds of exhibiting companies from dozens of countries and regions worldwide, as well as thousands of professional visitors, including pharmaceutical executives, R&D personnel, procurement managers, production managers, and regulatory representatives. During the exhibition, in addition to a rich display of exhibits, a series of high-level conferences, seminars, and specialized forums will be held to delve into cutting-edge technologies, market trends, regulatory policies, and investment opportunities, providing a comprehensive learning and exchange platform for attendees. The staging of CPHI Middle East not only promotes international cooperation and technological innovation in the regional pharmaceutical industry but also builds an efficient bridge for global pharmaceutical companies to enter the Middle Eastern market, holding profound significance for the development of healthcare in the Middle East.

The exhibit range of the 2026 CPHI Middle East International Pharmaceutical Ingredients Exhibition in Riyadh, Saudi Arabia, covers all aspects of the pharmaceutical industry chain, aiming to provide global pharmaceutical companies with a one-stop sourcing and cooperation platform. Key exhibit categories include: 1. **Active Pharmaceutical Ingredients (APIs) and Intermediates**: Various chemical synthesis APIs, natural extract APIs, biotechnology APIs, veterinary APIs, fine chemical intermediates, pharmaceutical excipients, etc., covering raw material products for multiple therapeutic areas such as cardiovascular, anti-infective, oncology, nervous system, and diabetes. 2. **Finished Dosage Forms and Finished Drugs**: Various oral solid dosage forms (tablets, capsules, granules), liquid dosage forms (oral solutions, injections), semi-solid dosage forms (ointments, gels), inhalation preparations, transdermal patches, biologics, vaccines, traditional Chinese medicines, OTC drugs, etc., as well as services from Contract Manufacturing Organizations (CMOs) and Contract Development and Manufacturing Organizations (CDMOs). 3. **Pharmaceutical Machinery and Equipment**: Tablet presses, capsule filling machines, packaging machines, filling machines, sterilization equipment, drying equipment, pulverizing equipment, mixing equipment, granulation equipment, testing equipment, laboratory instruments, cleanroom equipment, water treatment equipment, refrigeration equipment, pharmaceutical water systems, environmental protection equipment, etc., covering automated and intelligent solutions for the entire process of drug production, packaging, and testing. 4. **Pharmaceutical Packaging Materials and Systems**: Pharmaceutical glass bottles, plastic bottles, aluminum-plastic blister packs, aluminum foil, PTP aluminum foil, pharmaceutical soft tubes, pharmaceutical rubber stoppers, pharmaceutical cartons, labels, anti-counterfeiting packaging, child-resistant packaging, smart packaging, packaging design and printing services, etc., ensuring the safety and stability of drugs during storage and transportation. 5. **Biopharmaceuticals and Biotechnology**: Biopharmaceutical raw materials, bioactive substances, cell culture media, bioreactors, biological separation and purification technologies, genetic engineering drugs, antibody drugs, recombinant proteins, diagnostic reagents, biotechnology services, bioprocess solutions, etc., showcasing the latest R&D achievements and technological advancements in the biopharmaceutical field. 6. **Contract Services (CRO/CMO/CDMO)**: Pre-clinical research, clinical trials, drug analysis, quality control, regulatory submission, technology transfer, manufacturing outsourcing, packaging outsourcing, logistics services, consulting services, etc., providing comprehensive professional service support for pharmaceutical companies. 7. **Laboratory Equipment and Consumables**: Analytical instruments, testing equipment, chromatographs, spectrometers, mass spectrometers, centrifuges, incubators, pipettes, reagents, glassware, filter membranes, purification columns, etc., meeting the laboratory needs for pharmaceutical R&D and quality control. 8. **Other Related Products and Services**: Pharmaceutical excipients, intermediates, natural extracts, health product raw materials, veterinary drug raw materials, diagnostic reagent raw materials, pharmaceutical trade, logistics and supply chain management, industry media, associations, etc., collectively building a complete pharmaceutical ecosystem.

No fee information available. Please contact us for a quote.